Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 70669 to 201 of 201 entries
Sorted by: Best Match Show Resources per page
Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.

Nanomedicine (London, England)

Lepeltier EA, Nuhn L, Lehr CM, Zentel R.
PMID: 26447353
Nanomedicine (Lond). 2015;10(20):3147-66. doi: 10.2217/nnm.15.132. Epub 2015 Oct 08.

During the last 3 decades, nanomedicines have provided novel opportunities to improve the delivery of chemotherapeutics in cancer therapy effectively. However, many principles learnt from there have the potential to be transferred to other diseases. This perspective article, on...

Cite
Lepeltier EA, Nuhn L, Lehr CM, et al. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine. Nanomedicine (Lond). 2015;10(20):3147-66doi: 10.2217/nnm.15.132.
Lepeltier, E. A., Nuhn, L., Lehr, C. M., & Zentel, R. (2015). Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine. Nanomedicine (London, England), 10(20), 3147-66. https://doi.org/10.2217/nnm.15.132
Lepeltier, Elise Anne, et al. "Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine." Nanomedicine (London, England) vol. 10,20 (2015): 3147-66. doi: https://doi.org/10.2217/nnm.15.132
Lepeltier EA, Nuhn L, Lehr CM, Zentel R. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine. Nanomedicine (Lond). 2015;10(20):3147-66. doi: 10.2217/nnm.15.132. Epub 2015 Oct 08. PMID: 26447353.
Copy Download .nbib Format: NLM
Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach.

Advanced materials (Deerfield Beach, Fla.)

Molinaro R, Evangelopoulos M, Hoffman JR, Corbo C, Taraballi F, Martinez JO, Hartman KA, Cosco D, Costa G, Romeo I, Sherman M, Paolino D, Alcaro S, Tasciotti E.
PMID: 29512198
Adv Mater. 2018 Apr;30(15):e1702749. doi: 10.1002/adma.201702749. Epub 2018 Mar 07.

The advancement of nanotechnology toward more sophisticated bioinspired approaches has highlighted the gap between the advantages of biomimetic and biohybrid platforms and the availability of manufacturing processes to scale up their production. Though the advantages of transferring biological features...

Cite
Molinaro R, Evangelopoulos M, Hoffman JR, et al. Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach. Adv Mater. 2018;30(15):e1702749doi: 10.1002/adma.201702749.
Molinaro, R., Evangelopoulos, M., Hoffman, J. R., Corbo, C., Taraballi, F., Martinez, J. O., Hartman, K. A., Cosco, D., Costa, G., Romeo, I., Sherman, M., Paolino, D., Alcaro, S., & Tasciotti, E. (2018). Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach. Advanced materials (Deerfield Beach, Fla.), 30(15), e1702749. https://doi.org/10.1002/adma.201702749
Molinaro, Roberto, et al. "Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach." Advanced materials (Deerfield Beach, Fla.) vol. 30,15 (2018): e1702749. doi: https://doi.org/10.1002/adma.201702749
Molinaro R, Evangelopoulos M, Hoffman JR, Corbo C, Taraballi F, Martinez JO, Hartman KA, Cosco D, Costa G, Romeo I, Sherman M, Paolino D, Alcaro S, Tasciotti E. Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach. Adv Mater. 2018 Apr;30(15):e1702749. doi: 10.1002/adma.201702749. Epub 2018 Mar 07. PMID: 29512198.
Copy Download .nbib Format: NLM
[CONCISE NANOMEDICINE REVIEW].

Harefuah

Haddad M, Popovtzer R, Yariv I, Motiei M, Fixler D.
PMID: 29688641
Harefuah. 2018 Apr;157(4):232-236.

INTRODUCTION: Nanomedicine is a rapidly evolving medical domain utilizing 1-100nm nanoscale particles to achieve medical goals in either one or more medical aspects - diagnosis, imaging and therapy. Nanomedicine employs a combination of methods stemming from life and exact...

Cite
Haddad M, Popovtzer R, Yariv I, et al. [CONCISE NANOMEDICINE REVIEW]. Harefuah. 2018;157(4):232-236
Haddad, M., Popovtzer, R., Yariv, I., Motiei, M., & Fixler, D. (2018). [CONCISE NANOMEDICINE REVIEW]. Harefuah, 157(4), 232-236.
Haddad, Menashe, et al. "[CONCISE NANOMEDICINE REVIEW]." Harefuah vol. 157,4 (2018): 232-236.
Haddad M, Popovtzer R, Yariv I, Motiei M, Fixler D. [CONCISE NANOMEDICINE REVIEW]. Harefuah. 2018 Apr;157(4):232-236. Hebrew. PMID: 29688641.
Copy Download .nbib Format: NLM
The EsoCap-system - An innovative platform to drug targeting in the esophagus.

Journal of controlled release : official journal of the Controlled Release Society

Krause J, Rosenbaum C, Grimm M, Rump A, Keßler R, Hosten N, Weitschies W.
PMID: 32781172
J Control Release. 2020 Nov 10;327:1-7. doi: 10.1016/j.jconrel.2020.08.011. Epub 2020 Aug 08.

For the therapy of esophageal diseases such as eosinophilic esophagitis, there are no possibilities of local targeted therapy. This publication describes a novel, innovative drug delivery concept, that enables a targeted, long-lasting administration of drug substances to the esophageal...

Cite
Krause J, Rosenbaum C, Grimm M, et al. The EsoCap-system - An innovative platform to drug targeting in the esophagus. J Control Release. 2020;327:1-7doi: 10.1016/j.jconrel.2020.08.011.
Krause, J., Rosenbaum, C., Grimm, M., Rump, A., Keßler, R., Hosten, N., & Weitschies, W. (2020). The EsoCap-system - An innovative platform to drug targeting in the esophagus. Journal of controlled release : official journal of the Controlled Release Society, 3271-7. https://doi.org/10.1016/j.jconrel.2020.08.011
Krause, Julius, et al. "The EsoCap-system - An innovative platform to drug targeting in the esophagus." Journal of controlled release : official journal of the Controlled Release Society vol. 327 (2020): 1-7. doi: https://doi.org/10.1016/j.jconrel.2020.08.011
Krause J, Rosenbaum C, Grimm M, Rump A, Keßler R, Hosten N, Weitschies W. The EsoCap-system - An innovative platform to drug targeting in the esophagus. J Control Release. 2020 Nov 10;327:1-7. doi: 10.1016/j.jconrel.2020.08.011. Epub 2020 Aug 08. PMID: 32781172.
Copy Download .nbib Format: NLM
Nanomedicine and thermal therapies: where are we going?.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Bakuzis AF.
PMID: 33426998
Int J Hyperthermia. 2020 Dec;37(3):1-3. doi: 10.1080/02656736.2020.1854355.

No abstract available.

Cite
Bakuzis AF. Nanomedicine and thermal therapies: where are we going?. Int J Hyperthermia. 2020;37(3):1-3doi: 10.1080/02656736.2020.1854355.
Bakuzis, A. F. (2020). Nanomedicine and thermal therapies: where are we going?. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 37(3), 1-3. https://doi.org/10.1080/02656736.2020.1854355
Bakuzis, Andris F. "Nanomedicine and thermal therapies: where are we going?." International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group vol. 37,3 (2020): 1-3. doi: https://doi.org/10.1080/02656736.2020.1854355
Bakuzis AF. Nanomedicine and thermal therapies: where are we going?. Int J Hyperthermia. 2020 Dec;37(3):1-3. doi: 10.1080/02656736.2020.1854355. PMID: 33426998.
Copy Download .nbib Format: NLM
Interdependency of influential parameters in therapeutic nanomedicine.

Expert opinion on drug delivery

Kamali Shahri SM, Sharifi S, Mahmoudi M.
PMID: 33887999
Expert Opin Drug Deliv. 2021 Oct;18(10):1379-1394. doi: 10.1080/17425247.2021.1921732. Epub 2021 May 12.

No abstract available.

Cite
Kamali Shahri SM, Sharifi S, Mahmoudi M. Interdependency of influential parameters in therapeutic nanomedicine. Expert Opin Drug Deliv. 2021;18(10):1379-1394doi: 10.1080/17425247.2021.1921732.
Kamali Shahri, S. M., Sharifi, S., & Mahmoudi, M. (2021). Interdependency of influential parameters in therapeutic nanomedicine. Expert opinion on drug delivery, 18(10), 1379-1394. https://doi.org/10.1080/17425247.2021.1921732
Kamali Shahri, Seyed Mehdi, et al. "Interdependency of influential parameters in therapeutic nanomedicine." Expert opinion on drug delivery vol. 18,10 (2021): 1379-1394. doi: https://doi.org/10.1080/17425247.2021.1921732
Kamali Shahri SM, Sharifi S, Mahmoudi M. Interdependency of influential parameters in therapeutic nanomedicine. Expert Opin Drug Deliv. 2021 Oct;18(10):1379-1394. doi: 10.1080/17425247.2021.1921732. Epub 2021 May 12. PMID: 33887999.
Copy Download .nbib Format: NLM
Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation.

International journal of molecular sciences

Vianello F, Cecconello A, Magro M.
PMID: 34299242
Int J Mol Sci. 2021 Jul 16;22(14). doi: 10.3390/ijms22147625.

Aiming at creating smart nanomaterials for biomedical applications, nanotechnology aspires to develop a new generation of nanomaterials with the ability to recognize different biological components in a complex environment. It is common opinion that nanomaterials must be coated with...

Cite
Vianello F, Cecconello A, Magro M. Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation. Int J Mol Sci. 2021;22(14)doi: 10.3390/ijms22147625.
Vianello, F., Cecconello, A., & Magro, M. (2021). Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation. International journal of molecular sciences, 22(14), . https://doi.org/10.3390/ijms22147625
Vianello, Fabio, et al. "Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation." International journal of molecular sciences vol. 22,14 (2021). doi: https://doi.org/10.3390/ijms22147625
Vianello F, Cecconello A, Magro M. Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation. Int J Mol Sci. 2021 Jul 16;22(14). doi: 10.3390/ijms22147625. PMID: 34299242; PMCID: PMC8305441.
Copy Download .nbib Format: NLM
Clinical applications for exosomes: Are we there yet?.

British journal of pharmacology

Perocheau D, Touramanidou L, Gurung S, Gissen P, Baruteau J.
PMID: 33751579
Br J Pharmacol. 2021 Jun;178(12):2375-2392. doi: 10.1111/bph.15432. Epub 2021 May 03.

Exosomes are a subset of extracellular vesicles essential for cell-cell communication in health and disease with the ability to transport nucleic acids, functional proteins and other metabolites. Their clinical use as diagnostic biomarkers and therapeutic carriers has become a...

Cite
Perocheau D, Touramanidou L, Gurung S, et al. Clinical applications for exosomes: Are we there yet?. Br J Pharmacol. 2021;178(12):2375-2392doi: 10.1111/bph.15432.
Perocheau, D., Touramanidou, L., Gurung, S., Gissen, P., & Baruteau, J. (2021). Clinical applications for exosomes: Are we there yet?. British journal of pharmacology, 178(12), 2375-2392. https://doi.org/10.1111/bph.15432
Perocheau, Dany, et al. "Clinical applications for exosomes: Are we there yet?." British journal of pharmacology vol. 178,12 (2021): 2375-2392. doi: https://doi.org/10.1111/bph.15432
Perocheau D, Touramanidou L, Gurung S, Gissen P, Baruteau J. Clinical applications for exosomes: Are we there yet?. Br J Pharmacol. 2021 Jun;178(12):2375-2392. doi: 10.1111/bph.15432. Epub 2021 May 03. PMID: 33751579; PMCID: PMC8432553.
Copy Download .nbib Format: NLM
Anatomical Definition of the Target Structures of a Jet-Based Tissue Penetration.

Journal of drugs in dermatology : JDD

Sandhofer M, Barsch M, Sandhofer-Novak R, Kopper F, Vinshtok Y, Pilsl U.
PMID: 33938705
J Drugs Dermatol. 2021 May 01;20(5):571-574. doi: 10.36849/JDD.2080.

No abstract available.

Cite
Sandhofer M, Barsch M, Sandhofer-Novak R, et al. Anatomical Definition of the Target Structures of a Jet-Based Tissue Penetration. J Drugs Dermatol. 2021;20(5):571-574doi: 10.36849/JDD.2080.
Sandhofer, M., Barsch, M., Sandhofer-Novak, R., Kopper, F., Vinshtok, Y., & Pilsl, U. (2021). Anatomical Definition of the Target Structures of a Jet-Based Tissue Penetration. Journal of drugs in dermatology : JDD, 20(5), 571-574. https://doi.org/10.36849/JDD.2080
Sandhofer, Matthias, et al. "Anatomical Definition of the Target Structures of a Jet-Based Tissue Penetration." Journal of drugs in dermatology : JDD vol. 20,5 (2021): 571-574. doi: https://doi.org/10.36849/JDD.2080
Sandhofer M, Barsch M, Sandhofer-Novak R, Kopper F, Vinshtok Y, Pilsl U. Anatomical Definition of the Target Structures of a Jet-Based Tissue Penetration. J Drugs Dermatol. 2021 May 01;20(5):571-574. doi: 10.36849/JDD.2080. PMID: 33938705.
Copy Download .nbib Format: NLM
Showing 70669 to 201 of 201 entries